Literature DB >> 21177676

PCR-based amplification of heterogeneous IS257-ileS2 junctions for molecular monitoring of high-level mupirocin resistance in staphylococci.

Eduardo Pérez-Roth1, Estefanía Armas-González, Julia Alcoba-Flórez, Sebastián Méndez-Álvarez.   

Abstract

OBJECTIVES: Plasmids encoding the ileS2 gene are responsible for the wide spread of high-level mupirocin resistance in staphylococci, and consequent clinical and epidemiological problems. We investigated the location of insertion sequence IS257 flanking ileS2 in different plasmids and developed a method for molecular typing of the IS257-ileS2 spacer regions.
METHODS: Nine ileS2-encoding plasmids (i.e. pPR1-pPR9) classified into distinct structural groups (i.e. S1-S4) were analysed. Complete DNA sequences between IS257s flanking ileS2 were determined. A PCR-based amplification scheme was designed for the simultaneous amplification of up- and down-stream IS257-ileS2 regions. The method was applied to a total of 90 high-level mupirocin-resistant clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA).
RESULTS: pPR1-pPR9 possessed IS257s flanking ileS2. Plasmids of each structural group showed a unique configuration of IS257-ileS2 spacer regions. The PCR-based method permitted accurate typing of the heterogeneous IS257-ileS2 up- and down-stream junctions, and the differentiation of plasmids of each group. The results obtained corresponded with previous plasmid typing based on restriction enzyme analyses and ileS2 locus hybridization polymorphs. The application of the PCR-based method to a diverse collection of MRSA isolates carrying ileS2-encoding plasmids demonstrated its versatility and revealed extraordinary heterogeneity in the IS257-ileS2 spacers.
CONCLUSIONS: The devised PCR-based scheme offers a rapid, simple and effective approach for typing IS257-ileS2 configurations present on ileS2-encoding plasmids. Hopefully, it could serve as a useful molecular epidemiological tool to control high-level mupirocin resistance.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21177676     DOI: 10.1093/jac/dkq493

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  6 in total

Review 1.  Current and Emerging Topical Antibacterials and Antiseptics: Agents, Action, and Resistance Patterns.

Authors:  Deborah A Williamson; Glen P Carter; Benjamin P Howden
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

2.  Molecular characterization of high-level mupirocin resistance in Staphylococcus pseudintermedius.

Authors:  Krešimir Matanovic; Eduardo Pérez-Roth; Selma Pintarić; Branka Šeol Martinec
Journal:  J Clin Microbiol       Date:  2012-12-26       Impact factor: 5.948

3.  Emergence of ileS2-Carrying, Multidrug-Resistant Plasmids in Staphylococcus lugdunensis.

Authors:  Pak-Leung Ho; Melissa Chun-Jiao Liu; Kin-Hung Chow; Cindy Wing-Sze Tse; Wai-U Lo; Siu-Ka Mak; Wai-Kei Lo
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

4.  Prevalence of mupirocin resistance in Staphylococcus pseudintermedius.

Authors:  Stacey M Godbeer; Randi M Gold; Sara D Lawhon
Journal:  J Clin Microbiol       Date:  2014-01-29       Impact factor: 5.948

5.  Evolution of a 72-Kilobase Cointegrant, Conjugative Multiresistance Plasmid in Community-Associated Methicillin-Resistant Staphylococcus aureus Isolates from the Early 1990s.

Authors:  Karina Yui Eto; Neville Firth; Amy M Davis; Stephen M Kwong; Marcelina Krysiak; Yung Thin Lee; Frances G O'Brien; Warren B Grubb; Geoffrey W Coombs; Charles S Bond; Joshua P Ramsay
Journal:  Antimicrob Agents Chemother       Date:  2019-10-22       Impact factor: 5.191

6.  Topical Antibiotic Use Coselects for the Carriage of Mobile Genetic Elements Conferring Resistance to Unrelated Antimicrobials in Staphylococcus aureus.

Authors:  Glen P Carter; Mark B Schultz; Sarah L Baines; Anders Gonçalves da Silva; Helen Heffernan; Audrey Tiong; Peter H Pham; Ian R Monk; Timothy P Stinear; Benjamin P Howden; Deborah A Williamson
Journal:  Antimicrob Agents Chemother       Date:  2018-01-25       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.